Hilltop National Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$823K Sell
9,101
-332
-4% -$27.8K 0.18% 118
2026
Q1
$755K Buy
9,433
+233
+3% +$19.2K 0.18% 121
2025
Q4
$784K Buy
9,200
+620
+7% +$50.9K 0.19% 112
2025
Q3
$667K Sell
8,580
-276
-3% -$21.6K 0.16% 125
2025
Q2
$693K Buy
+8,856
New +$660K 0.18% 124
2024
Q4
$635K Hold
8,580
0.19% 122
2024
Q3
$566K Hold
8,580
0.17% 126
2024
Q2
$793K Hold
8,580
0.25% 105
2024
Q1
$820K Buy
+8,580
New +$721K 0.28% 106

Other funds holding EW

Hilltop National Bank's EW Position: Q2 2026 in Review

Hilltop National Bank reduced its Edwards Lifesciences (EW) stake by 3.5% in Q2 2026, selling an estimated $27.8K and leaving 9,101 shares worth $823K. The position accounts for 0.18% of the portfolio, ranked #118.

Hilltop National Bank first reported a position in EW in Q1 2024 and has held it in 9 quarters since. 350 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Hilltop National Bank held 9,101 shares of Edwards Lifesciences worth $823K as of Q2 2026.
  • Hilltop National Bank sold 332 Edwards Lifesciences shares in Q2 2026, an estimated $27.8K.
  • Edwards Lifesciences made up 0.18% of Hilltop National Bank's portfolio in Q2 2026, its #118 holding.
  • Hilltop National Bank first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 9 quarters since.
  • 350 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.